| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
![4-氨基-1-叔丁基-3-(1`-萘)吡唑并[3,4-d]嘧啶](http://www.invivochem.com/upload/0201/CgAH6F3ChZCAGm0HAAAe23qmUX0246.png)
|
V3630 | 1-Naphthyl PP1(1-NA-PP 1) | 221243-82-9 | 1-Naphthyl PP1 (also known as 1-NA-PP1) is a novel, potent and selective ATP-competitive inhibitor of src family kinases v-Src and c-Fyn as well as the tyrosine kinase c-Abl with IC50 values of 1.0, 0.6, 0.6, 18 and 22 μM for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II respectively. |
|
V69771 | Antiallergic agent-1 | 2839159-12-3 | Antiallergic agent-1 is a Src family kinase inhibitor and may serve as a new valuable lead compound for the discovery of antiallergic active molecules in the future. |
|
V2984 | AZM475271 | 476159-98-5 | AZM475271 is a potent, selective and oral inhibitor of Src kinase with IC50 of 5 nM and with potential anticancer activities; it has no inhibitory activity on Flt3, KDR, Tie-2. |
|
V2889 | KX1-004 | 518058-84-9 | KX1-004 is a novel and potent small molecule inhibitor of Src-protein tyrosine kinase that can be used to reduce cisplatin ototoxicity while preserving its antitumor effect. |
|
V0668 | PP1 | 172889-26-8 | PP1 (known also as EI275; EI-275; PP-1; PP 1; AG1872; AG-1872) is a novel, potent and selective Src kinase inhibitor with potential antitumor activity. |
|
V144110 | Rhodomycin A | 23666-50-4 | Rodolmycin A can inhibit lung cancer cell progression by regulating the Src-related pathway. |
|
V144694 | Scr-IN-1 | Scr-IN-1 is a tyrosine kinase inhibitor. | |
|
V145254 | Src Inhibitor 4 | Src Inhibitor 4 is a derivative of KX-01 and is also a Src inhibitor. | |
|
V145290 | STAT-3/c-Src-IN-1 | STAT-3/c-Src-IN-1 is a dual STAT-3 (IC50=0.844 μM) and c-Src (IC50=0.268 μM) inhibitor. | |
|
V0669 | SU6656 | 330161-87-0 | SU 6656 (SU-6656) is a novel, potent and selective Src family kinase (Src, Yes, Lyn, and Fyn) inhibitor with potential antineoplastic activity. |
|
V146692 | Tyrosine Kinase Peptide 1 acetate | Tyrosine Kinase Peptide 1 acetate is a control substrate peptide for c-Src assay. | |
|
V0670 | WH-4-023 | 837422-57-8 | WH-4-023 (also called KIN112;WH-4023;KIN-001-112) is a novel, potent,selectiveand orally bioactive inhibitor ofSrc family kinase(dual Lck/Src inhibitor)with potential anti-inflammatory and anticancer activity. |
|
V0665 | Bosutinib (SKI-606; Bosulif) | 380843-75-4 | Bosutinib (formerly also known as SKI-606; trade name Bosulif) is a novel, quinolone-based, andpotent dual Src/Abl kinase inhibitor with potential antitumor activity. |
|
V0664 | Saracatinib (AZD0530) | 379231-04-6 | Saracatinib (formerly also known as AZD-0530; AZD0530) is a novel, potent Src kinase inhibitor with potential antineoplastic activity. |
|
V0666 | Tirbanibulin (KX2391; KX-O1) | 897016-82-9 | Tirbanibulin (also known as KXO1; KX2-391; Klisyri) is novel, potent and the first clinical peptidomimetic Src kinase inhibitor as well as a mitotic/tubulin inhibitor with potential anticancer activity. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
